stella
beta
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) — Stella
Recruiting
Back to Head and Neck Squamous Cell Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(2 sites)
China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei
West China Hospital of Sichuan University, Chengdu, Sichuan
View full record on ClinicalTrials.gov